AIMC Topic: Molecular Structure

Clear Filters Showing 291 to 300 of 329 articles

ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery.

Briefings in bioinformatics
An unsolved challenge in developing molecular representation is determining an optimal method to characterize the molecular structure. Comprehension of intramolecular interactions is paramount toward achieving this goal. In this study, ComABAN, a new...

ABC-Net: a divide-and-conquer based deep learning architecture for SMILES recognition from molecular images.

Briefings in bioinformatics
Structural information for chemical compounds is often described by pictorial images in most scientific documents, which cannot be easily understood and manipulated by computers. This dilemma makes optical chemical structure recognition (OCSR) an ess...

Molecular persistent spectral image (Mol-PSI) representation for machine learning models in drug design.

Briefings in bioinformatics
Artificial intelligence (AI)-based drug design has great promise to fundamentally change the landscape of the pharmaceutical industry. Even though there are great progress from handcrafted feature-based machine learning models, 3D convolutional neura...

Fighting COVID-19 with Artificial Intelligence.

Methods in molecular biology (Clifton, N.J.)
The development of vaccines for the treatment of COVID-19 is paving the way for new hope. Despite this, the risk of the virus mutating into a vaccine-resistant variant still persists. As a result, the demand of efficacious drugs to treat COVID-19 is ...

Predicting Drug-Target Affinity Based on Recurrent Neural Networks and Graph Convolutional Neural Networks.

Combinatorial chemistry & high throughput screening
BACKGROUND: Drug development requires a lot of money and time, and the outcome of the challenge is unknown. So, there is an urgent need for researchers to find a new approach that can reduce costs. Therefore, the identification of drug-target interac...

Utilizing graph machine learning within drug discovery and development.

Briefings in bioinformatics
Graph machine learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst...

Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method.

Briefings in bioinformatics
Accurate predictions of druggability and bioactivities of compounds are desirable to reduce the high cost and time of drug discovery. After more than five decades of continuing developments, quantitative structure-activity relationship (QSAR) methods...

Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction.

Briefings in bioinformatics
Molecular descriptors are essential to not only quantitative structure activity/property relationship (QSAR/QSPR) models, but also machine learning based chemical and biological data analysis. In this paper, we propose persistent spectral hypergraph ...

A spatial-temporal gated attention module for molecular property prediction based on molecular geometry.

Briefings in bioinformatics
MOTIVATION: Geometry-based properties and characteristics of drug molecules play an important role in drug development for virtual screening in computational chemistry. The 3D characteristics of molecules largely determine the properties of the drug ...

Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction.

Briefings in bioinformatics
Structure-based virtual screenings (SBVSs) play an important role in drug discovery projects. However, it is still a challenge to accurately predict the binding affinity of an arbitrary molecule binds to a drug target and prioritize top ligands from ...